Definately a positive step. Acceptance by the masses may take time......but all market place acceptance of new products has to start somewhere.
remember that not all ccongenital cardiac surgeries rewuire a patch material to be used ( many ASD & AVD are simply sewn closed)...and this is not necesssrily the 3D marke pllace.......but a reasonable ptoertion will....even at 20% that......not a massive game changer...but steady income ......and product promotion thrown in.........
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-551
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
-0.550(3.10%) |
Mkt cap ! $330.6M | |||
| Open | High | Low | Value | Volume |
| $17.75 | $17.75 | $16.88 | $199.1K | 11.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |